Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.
about
Review of vancomycin-induced renal toxicity: an updateOptimizing the Clinical Use of VancomycinVancomycin dosing in neutropenic patientsOptimization of time to initial vancomycin target trough improves clinical outcomesTraditional weight-based vancomycin dosing is inadequate in critically ill trauma patients.Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.A survey on infection management practices in Italian ICUsVancomycin dosing and monitoring 2 years after the guidelines.Vancomycin: a review of population pharmacokinetic analyses.Approaches for dosage individualisation in critically ill patients.Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.Population pharmacometrics in support of analgesics studies.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients.Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.A Rapid and Simple HPLC Method for Therapeutic Monitoring of Vancomycin.Vancomycin dose adjustment in severe burn patients based on trough level for drug effectiveness against pathogens at 1 mg/l minimum inhibitory concentration.
P2860
Q26746932-CC92C1E9-3AC8-4404-871D-5CA931C85C8DQ28069334-774B22D5-11E8-4957-AE92-9FA1D39C1310Q28544891-53D90A00-826A-44C6-B384-6EED6D87FB56Q35862844-34B5EF8C-7011-4071-A3FB-9CC319921D15Q35905703-A2A04EC5-E4E9-4561-BC2D-01CABB897D25Q36571794-0C2AB8A0-13E3-4CC0-B9BE-FCE56AF9DD54Q36902763-953051E5-FEA7-4D72-8AA7-6E319B5F505EQ37892556-00F94E00-25E2-4524-93E7-4E85C44C7BC7Q37965578-DE29DF71-C0E5-4BC6-B804-6A9A8893E4E6Q38125209-87725C14-6330-4A2E-82B6-ACFD11FBCC6CQ38137251-8FE66F9A-4AEA-4E9C-BA3C-8FB178AA56CBQ38167345-065F707A-5C7B-46C4-B4E8-214AFC50871EQ38175171-05FBC1FA-E0D2-41F6-8261-F2BB89E6731EQ38258649-538B5941-3689-4588-9A88-53524D433389Q39386583-583B2377-4C33-4776-A9F8-8F4FA051C89FQ40481176-38A14A54-ED6A-4636-9A2A-6D9A05D93E34Q40672214-2C3189F4-A22C-440B-A8F6-4961E31231CDQ42689710-3EF30141-7D0B-4908-98DE-231816B6C819Q47605331-EC0E412C-7FE5-481C-8661-8AB9A9D19183Q55442782-C5D08B8F-C45F-4EFA-AEAE-E7970DD96AAC
P2860
Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@ast
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@en
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@nl
type
label
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@ast
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@en
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@nl
prefLabel
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@ast
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@en
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@nl
P2093
P2860
P1476
Vancomycin dosing assessment i ...... ic/pharmacodynamic simulation.
@en
P2093
Ana Martín-Suárez
Félix Martín González
Marta Paz Pérez
María Del Mar Fernández de Gatta
Natalia Revilla
P2860
P304
P356
10.1111/J.1365-2125.2010.03679.X
P407
P577
2010-08-01T00:00:00Z